Are Options Traders Bullish on ALNY?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

About ALNY

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is leading the translation of RNAi as a new class of innovative medicines. Alnylams pipeline of investigational RNAi therapeutics is focused in 3 Strategic Therapeutic Areas (STArs): Genetic Medicines, with a broad pipeline of RNAi therapeutics for the treatment of rare diseases; Cardio-Metabolic Disease, with a pipeline of RNAi therapeutics toward genetically validated, liver-expressed disease targets for unmet needs in cardiovascular and metabolic diseases; and Hepatic Infectious Disease, with a pipeline of RNAi therapeutics that address the major global health challenges of hepatic infectious diseases. In early 2015, Alnylam launched its Alnylam 2020 guidance for the advancement and commercialization of RNAi therapeutics as a whole new class of innovative medicines. Specifically, by the end of 2020, Alnylam expects to achieve a company profile with 3 marketed products, 10 RNAi therapeutic clinical programs including 4 in late stages of development across its 3 STArs. The companys demonstrated commitment to RNAi therapeutics has enabled it to form major alliances with leading companies including Merck, Medtronic, Novartis, Biogen, Roche, Takeda, Kyowa Hakko Kirin, Cubist, GlaxoSmithKline, Ascletis, Monsanto, The Medicines Company, and Genzyme, a Sanofi company. In addition, Alnylam holds an equity position in Regulus Therapeutics Inc., a company focused on discovery, development, and commercialization of microRNA therapeutics. Founded in 2002, Alnylam maintains headquarters in Cambridge, Massachusetts. www.alnylam.com.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ALNY is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BBH VanEck Vectors Biotech ETF 411.2 M 4.112E+08 25 25 1.85% 0.0185 7.6 M 7618910
BIB ProShares Ultra Nasdaq Biotechnology 274.1 M 2.74063E+08 235 235 0.4% 0.0040091 2.4 M 2405070
EQAL Invesco Russell 1000 Equal Weight ETF 376.6 M 3.766E+08 968 968 0.12% 0.00117 433 K 432951
EQWM Invesco Russell Midcap Equal Weight ETF 23.0 M 2.3E+07 776 776 0.17% 0.00171 39 K 38984
EUSA iShares MSCI USA Equal Weighted ETF 213.3 M 2.133E+08 620 620 0.17% 0.0017 366 K 365901
FBT First Trust Amex Biotech Index Fund 2.7 B 2.66064E+09 30 30 3.58% 0.0358 95.3 M 9.525091E+07
FHLC Fidelity MSCI Health Care Index ETF 1.5 B 1.5E+09 357 357 0.19% 0.00187611 2.8 M 2817130
FTLS First Trust Long/Short Equity 200.7 M 2.00668E+08 245 245 -0.27% -0.0027 -518 K -517632
IBB iShares Nasdaq Biotechnology Index Fund 8.2 B 8.22605E+09 224 224 1.11% 0.0111 90.0 M 9.00245E+07
ITOT iShares Core S&P Total U.S. Stock Market ETF 16.5 B 1.65381E+10 3,387 3387 0.03% 0.0003 4.5 M 4541980
IWB iShares Russell 1000 ETF 18.7 B 1.86635E+10 982 982 0.03% 0.0003 5.4 M 5363880
IWD iShares Russell 1000 Value ETF 38.3 B 3.83025E+10 724 724 0.01% 0.0001 2.5 M 2549900
IWF iShares Russell 1000 Growth ETF 40.2 B 4.0216E+10 546 546 0.05% 0.0005 20.7 M 2.068E+07
IWP iShares Russell Midcap Growth ETF 9.2 B 9.18426E+09 418 418 0.23% 0.0023 20.9 M 2.09479E+07
IWR iShares Russell Mid-Cap ETF 17.5 B 1.74501E+10 788 788 0.11% 0.0011 18.6 M 1.85726E+07
IWS iShares Russell Mid-cap Value ETF 10.7 B 1.07016E+10 591 591 0.02% 0.0002 2.2 M 2169040
IWV iShares Russell 3000 ETF 9.5 B 9.52999E+09 2,990 2990 0.03% 0.0003 2.6 M 2561470
IYH iShares U.S. Healthcare ETF 2.4 B 2.4281E+09 128 128 0.2% 0.002 4.9 M 4851830
IYY iShares Dow Jones U.S. ETF 1.1 B 1.12327E+09 1,232 1232 0.03% 0.0003 319 K 318748
JKH iShares Morningstar Mid-Cap Growth ETF 302.9 M 3.02946E+08 200 200 0.41% 0.0041 1.2 M 1229940
LABU Direxion Daily S&P Biotech Bull 3X Shares 588.0 M 5.88013E+08 129 129 0.01% 6.29138E-05 149 K 149258
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.7 B 1.7E+09 1,015 1015 0.07% 0.000650712 1.1 M 1132400
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 2.1 B 2.072E+09 1,430 1430 0.04% 0.00035 717 K 716597
QUS SPDR MSCI USA StrategicFactors ETF 139.8 M 1.3979E+08 616 616 0.0% 1.795E-05 3 K 2507
RXL ProShares Ultra Health Care 115.8 M 1.15796E+08 139 139 0.08% 0.000806037 199 K 199360
SIZE iShares Edge MSCI USA Size Factor ETF 220.6 M 2.20607E+08 620 620 0.19% 0.0019 418 K 417826
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.3 B 1.34684E+09 2,017 2017 0.02% 0.000244 325 K 325302
UBIO Proshares UltraPro Nasdaq Biotechnology 34.6 M 3.45696E+07 229 229 0.24% 0.00241934 274 K 273828
XBI SPDR Series Trust SPDR S&P Biotech ETF 4.1 B 4.07801E+09 122 122 1.31% 0.0130666 52.4 M 5.242787E+07

Wait, Before You Leave...